Search
×
E-mail
Bioprocessing Company News

Company News

Biolink Secures Hundreds of Millions RMB New Financing to Fuel Innovations in Bioprocessing “Made in China” 14 2024.11
Biolink Secures Hundreds of Millions RMB New Financing to Fuel Innovations in Bioprocessing “Made in China”
Today, Biolink is pleased to announce the successful completion of a new multi-hundred million RMB strategic financing round. This round was led by Cathay Capital and included participation from disti...
BioLink Formally Announces Its India Office Now Is Fully Functional And Operational 25 2024.04
BioLink Formally Announces Its India Office Now Is Fully Functional And Operational
Shanghai, China, April 15, 2024 - BioLink, a high-tech group enterprise equipped with state-of-the-art technology, specializing in the development and production of innovative bioprocessing products, ...
iF Design Winner: BioHub<sup>®</sup> DS Single-Use Desktop Mixing System 06 2024.03
iF Design Winner: BioHub® DS Single-Use Desktop Mixing System
Recently, the 'iF Design Award', one of the world's three major design awards, officially announced its list of winners for the year 2024. In the list of awards, the BioHub® DS Single-U...
BioLink Successfully Completes Series A+ Strategic Financing, Continues to Empower China's Bioprocessing with Innovation 21 2024.02
BioLink Successfully Completes Series A+ Strategic Financing, Continues to Empower China's Bioprocessing with Innovation
Today, BioLink proudly announced its successful completion of Series A+ strategic financing at the beginning of the Chinese Loong Year. This round of funding, led by Asymchem, Bridge Hill Capital, One...
BioLink and Verdot Forge Strategic Partnership to Advance Bioprocessing Technologies in China 09 2024.01
BioLink and Verdot Forge Strategic Partnership to Advance Bioprocessing Technologies in China
BioLink, a prominent Chinese bioprocessing company, and the French downstream bioprocessing company Verdot signed a strategic partnership agreement that marks a significant step forward in the field o...
Continuously Ranked | BioLink Named One of China's Top 100 Life Science Service Brands 10 2023.12
Continuously Ranked | BioLink Named One of China's Top 100 Life Science Service Brands
On November 3, 2023, the renowned media E Pharmaceutical Manager of China's medical and health industry officially released the list of 'Top 100 Chinese Life Science Service Enterprise Brands...
Grand Opening of BioLink Chromatography Resin Manufacturing Site Phase II, Boosting Annual Production Capacity to 120,000 Liters 12 2023.07
Grand Opening of BioLink Chromatography Resin Manufacturing Site Phase II, Boosting Annual Production Capacity to 120,000 Liters
Upgrade of Chromatography Resin Manufacturing Site in Lanzhou, Empowering Safe, Efficient, and Sustainable Biopharmaceutical Separation and Purification Technology On June 30, 2023, the commissioning ...
BioLink and BioValley Jointly Launch the ''Cell Therapy R&D Illustrated Handbook'' 02 2022.08
BioLink and BioValley Jointly Launch the ''Cell Therapy R&D Illustrated Handbook''
CAR-T cell therapy has now become a new choice for tumor patients. Based on the high efficacy of CAR-T cell therapy shown in clinical studies, many front-line medical workers, patients and their families, and investigators in this field are very optimistic about it.
BioLink Debuts At Analytica 2022 In Munich With Widely-applauded Superb Products 02 2022.08
BioLink Debuts At Analytica 2022 In Munich With Widely-applauded Superb Products
From June 21 to 24, BioLink made a stunning appearance with a series of new products at Analytica 2022 (Analytic & Laboratory Equipment Expo) held in Munich Exhibition Center , Germany after continuous R&D and innovation.
BioLink's Single-Use Bags Pass The DMF Filing 02 2022.08
BioLink's Single-Use Bags Pass The DMF Filing
Recently, the single-use multilayer co-extruded bags produced by Bio-Link have passed the DMF filing (FDA DMF filing No.: 037110) of the U.S.
BioLink Has Been Certified With ''ISO 13485:2016'' 20 2022.06
BioLink Has Been Certified With ''ISO 13485:2016''
After being certified with "ISO 9001:2015", recently, BioLink Phas have been certified with "ISO 13485:2016" successfully after a strict and detailed review by the third-party testing and certification body.
Ding Xinghua, Deputy Secretary of Rugao Municipal Party Committee, Visited BioLink Factory Again 20 2022.06
Ding Xinghua, Deputy Secretary of Rugao Municipal Party Committee, Visited BioLink Factory Again
This is the second time that Secretary Ding visited the company after one month, which fully shows the high concern and expectation that the Rugao Municipal Committee holds for the development of BioLink.
Ding Xinghua, Deputy Secretary of Rugao Municipal Party Committee, Visited BioLink For Inspection 20 2022.06
Ding Xinghua, Deputy Secretary of Rugao Municipal Party Committee, Visited BioLink For Inspection
On the afternoon of Aug. 25, Ding Xinghua, Deputy Secretary of Rugao Municipal Committee and Deputy Secretary of the Party Working Committee of Rugao Economic and Technological Development Zone, and his party visited BioLink to inspect the construction of the biopharmaceutical single-use consumables manufacturing site.
BioLink Attended 2021 Suzhou Wuzhong Taihu Lake Economic and Trade Cooperation Fair 20 2022.06
BioLink Attended 2021 Suzhou Wuzhong Taihu Lake Economic and Trade Cooperation Fair
On Oct. 18, 2021 Suzhou Wuzhong Taihu Lake Economic and Trade Cooperation Fair (hereinafter referred to as 'economic and trade fair') was grandly held on the shore of the beautiful Taihu Lake.
BioLink Participation | 2021 5th China Bio-pharm Innovation Cooperation Conference 20 2022.06
BioLink Participation | 2021 5th China Bio-pharm Innovation Cooperation Conference
The 2021 5th China Bio-Pharm Innovation Cooperation Conference was held in Guangzhou during Nov. 4 to 5, 2021, attracting more than 900 industry representatives on the first day.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
Reject Accept